Genmab COO appointed to board of influential biotech association

Anthony Mancini, current COO of Genmab, will join representatives from biotech companies and academic institutions from over 30 countries worldwide, including the US.

Anthony Mancini, chief operating officer at Genmab | Photo: Genmab

Genmab is gaining a seat at the table of one of the world’s biggest life science trade associations, Biotechnology Innovation Organization, Bio, the biotech company announces in a post on Linkedin.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs